Modular multi-source prediction of drug side-effects with DruGNN

• URL: http://arxiv.org/abs/2202.08147v1
• Date: Tue, 15 Feb 2022 09:41:05 GMT
• Title: Modular multi-source prediction of drug side-effects with DruGNN
• Authors: Pietro Bongini, Franco Scarselli, Monica Bianchini, Giovanna Maria Dimitri, Niccol\`o Pancino, Pietro Li\`o
• Abstract summary: Drug Side-Effects (DSEs) have a high impact on public health, care system costs, and drug discovery processes. To predict their occurrence, it is necessary to integrate data from heterogeneous sources. In this work, such heterogeneous data is integrated into a graph dataset, expressively representing the relational information between different entities. Graph Neural Networks (GNNs) are exploited to predict DSEs on our dataset with very promising results.
• Score: 3.229607826010618
• License: http://creativecommons.org/licenses/by-nc-nd/4.0/
• Abstract: Drug Side-Effects (DSEs) have a high impact on public health, care system costs, and drug discovery processes. Predicting the probability of side-effects, before their occurrence, is fundamental to reduce this impact, in particular on drug discovery. Candidate molecules could be screened before undergoing clinical trials, reducing the costs in time, money, and health of the participants. Drug side-effects are triggered by complex biological processes involving many different entities, from drug structures to protein-protein interactions. To predict their occurrence, it is necessary to integrate data from heterogeneous sources. In this work, such heterogeneous data is integrated into a graph dataset, expressively representing the relational information between different entities, such as drug molecules and genes. The relational nature of the dataset represents an important novelty for drug side-effect predictors. Graph Neural Networks (GNNs) are exploited to predict DSEs on our dataset with very promising results. GNNs are deep learning models that can process graph-structured data, with minimal information loss, and have been applied on a wide variety of biological tasks. Our experimental results confirm the advantage of using relationships between data entities, suggesting interesting future developments in this scope. The experimentation also shows the importance of specific subsets of data in determining associations between drugs and side-effects.

Related papers

• GramSeq-DTA: A grammar-based drug-target affinity prediction approach fusing gene expression information [1.2289361708127877]
  We propose GramSeq-DTA, which integrates chemical perturbation information with the structural information of drugs and targets. Our approach outperforms the current state-of-the-art DTA prediction models when validated on widely used DTA datasets.
  arXiv  Detail & Related papers  (2024-11-03T03:17:09Z)
• Learning to Denoise Biomedical Knowledge Graph for Robust Molecular Interaction Prediction [50.7901190642594]
  We propose BioKDN (Biomedical Knowledge Graph Denoising Network) for robust molecular interaction prediction. BioKDN refines the reliable structure of local subgraphs by denoising noisy links in a learnable manner. It maintains consistent and robust semantics by smoothing relations around the target interaction.
  arXiv  Detail & Related papers  (2023-12-09T07:08:00Z)
• Removing Biases from Molecular Representations via Information Maximization [16.38589836748167]
  InfoCORE is an Information approach for COnfounder REmoval to deal with batch effects. It adaptively reweighs samples to equalize their implied batch distribution. It offers a versatile framework and resolves general distribution shifts and issues of data fairness.
  arXiv  Detail & Related papers  (2023-12-01T16:53:15Z)
• Emerging Drug Interaction Prediction Enabled by Flow-based Graph Neural Network with Biomedical Network [69.16939798838159]
  We propose EmerGNN, a graph neural network (GNN) that can effectively predict interactions for emerging drugs. EmerGNN learns pairwise representations of drugs by extracting the paths between drug pairs, propagating information from one drug to the other, and incorporating the relevant biomedical concepts on the paths. Overall, EmerGNN has higher accuracy than existing approaches in predicting interactions for emerging drugs and can identify the most relevant information on the biomedical network.
  arXiv  Detail & Related papers  (2023-11-15T06:34:00Z)
• PGraphDTA: Improving Drug Target Interaction Prediction using Protein Language Models and Contact Maps [4.590060921188914]
  Key aspect of drug discovery involves identifying novel drug-target (DT) interactions. Protein-ligand interactions exhibit a continuum of binding strengths, known as binding affinity. We propose novel enhancements to enhance their performance.
  arXiv  Detail & Related papers  (2023-10-06T05:00:25Z)
• Drug Synergistic Combinations Predictions via Large-Scale Pre-Training and Graph Structure Learning [82.93806087715507]
  Drug combination therapy is a well-established strategy for disease treatment with better effectiveness and less safety degradation. Deep learning models have emerged as an efficient way to discover synergistic combinations. Our framework achieves state-of-the-art results in comparison with other deep learning-based methods.
  arXiv  Detail & Related papers  (2023-01-14T15:07:43Z)
• DDoS: A Graph Neural Network based Drug Synergy Prediction Algorithm [0.521420263116111]
  We introduce a Graph Neural Network (textitGNN) based model for drug synergy prediction. In contrast to conventional models, our GNN-based approach learns task-specific drug representations directly from the graph structure of the drugs. Our work suggests that learning task-specific drug representations and leveraging a diverse dataset is a promising approach to advancing our understanding of drug-drug interaction and synergy.
  arXiv  Detail & Related papers  (2022-10-03T10:16:29Z)
• SSM-DTA: Breaking the Barriers of Data Scarcity in Drug-Target Affinity Prediction [127.43571146741984]
  Drug-Target Affinity (DTA) is of vital importance in early-stage drug discovery. wet experiments remain the most reliable method, but they are time-consuming and resource-intensive. Existing methods have primarily focused on developing techniques based on the available DTA data, without adequately addressing the data scarcity issue. We present the SSM-DTA framework, which incorporates three simple yet highly effective strategies.
  arXiv  Detail & Related papers  (2022-06-20T14:53:25Z)
• MOOMIN: Deep Molecular Omics Network for Anti-Cancer Drug Combination Therapy [2.446672595462589]
  We propose a multimodal graph neural network that can predict the synergistic effect of drug combinations for cancer treatment. Our model captures the representation based on the context of drugs at multiple scales based on a drug-protein interaction network and metadata. We demonstrate that the model makes high-quality predictions over a wide range of cancer cell line tissues.
  arXiv  Detail & Related papers  (2021-10-28T13:10:25Z)
• HINT: Hierarchical Interaction Network for Trial Outcome Prediction Leveraging Web Data [56.53715632642495]
  Clinical trials face uncertain outcomes due to issues with efficacy, safety, or problems with patient recruitment. In this paper, we propose Hierarchical INteraction Network (HINT) for more general, clinical trial outcome predictions.
  arXiv  Detail & Related papers  (2021-02-08T15:09:07Z)
• SumGNN: Multi-typed Drug Interaction Prediction via Efficient Knowledge Graph Summarization [64.56399911605286]
  We propose SumGNN: knowledge summarization graph neural network, which is enabled by a subgraph extraction module. SumGNN outperforms the best baseline by up to 5.54%, and the performance gain is particularly significant in low data relation types.
  arXiv  Detail & Related papers  (2020-10-04T00:14:57Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.